Transparency Over Bans: How to Regulate This Technology
Instead of banning embryo selection, the guest advocates for transparency: companies should publish validation studies and ancestry-specific accuracy data so consumers can make informed decisions.
- Regulation should focus on truth in advertising and scientific rigor.
- Public access to validation studies prevents manipulation.
- Future competition will improve scores and lower costs.
- Open-source polygenic catalogs already exist but vary in quality.
“Governments should require companies to publish their validation studies... how much variation your predictors explain, and how they work across ancestry groups.”